Breakthrough Psychedelics is an educational journey into the re-emerging world of psychedelic therapies, offering a comprehensive exploration of three breakthrough psychedelics: MDMA, psilocybin, and ketamine. As these substances gain recognition for their potential therapeutic applications, this course provides valuable insights into their clinical science, pharmacology, and contextual use. Whether you are a healthcare professional seeking to incorporate this knowledge into client care or a curious individual interested in understanding the fascinating realm of psychedelics, this course offers a deep dive into these substances’ core principles, safety profiles, and therapeutic potential.
Structured into six sections with bite-sized modules, this course allows learners to progress at their own pace, providing approximately seven hours of online home study for completion. From exploring the fundamentals of psychedelics and their impact on mental and physical illnesses to delving into the neurobiology of psychedelics, participants will develop a solid foundation in the pharmacodynamics and pharmacokinetics of MDMA, psilocybin, and ketamine.
The course also covers potential uses and indications, safety profiles, adverse effects, and drug interactions. By the end of the course, learners will gain a comparative understanding of these three breakthrough psychedelics and explore various contexts of use, including self or home use, ritual use, and psychedelic-assisted therapy.